Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

MGKL revenue in January increased 4.7 times

2/3/25 MGKL

SPB Exchange summarized the results of trading in 2024

1/31/25 SPBE

Shares of Ashinskiy Metzavod will cease to be traded from March 13

1/31/25 AMEZ

Smarttechgroup will allocate 50% of its profits to dividends

1/31/25 CARM

Fesco increased transportation through land border crossings from China by 66%

1/31/25 FESH

Unipro's output in 2024 increased by 0.4%

1/31/25 UPRO

Smarttechgroup aims to earn ₽3 billion in profits by 2028

1/31/25 CARM

Astra distributed 464 thousand shares under the incentive program

1/31/25 ASTR

O'Key's 2024 revenue growth of 5.5%

1/31/25 OKEY

Ural-VK buys shares from minority shareholders of Ashinskiy Metzavod

1/31/25 AMEZ